Adcetris [prescribing information]. Bothell, WA: Seattle Genetics, Inc; September 2016.
Arzerra [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; August 2016.
Avastin [prescribing information]. South San Francisco, CA: Genentech, Inc; December 2016.
Blincyto [prescribing information]. Thousand Oaks, CA: Amgen Inc; September 2016.
Campath [prescribing information]. Cambridge, MA: Genzyme Corporation; September 2014.
Cervarix [prescribing information]. Triangle Park, NC: GlaxoSmithKline Biologicals; April 2016.
Cyramza [prescribing information]. Indianapolis, IN: Eli Lilly and Company; October 2016.
Darzalex [prescribing information]. Horsham, PA: Janssen Biotech, Inc; November 2016.
Ejection fraction. Cleveland Clinic Web site. http://my.clevelandclinic.org/health/articles/ejection-fraction. Updated January 2016. Accessed February 1, 2017.
Empliciti [prescribing information]. Princeton, NJ: Bristol-Myers Squibb Company; November 2015.
Erbitux [prescribing information]. Branchburg, NJ: ImClone LLC; October 2016.
Gardasil [prescribing information]. Whitehouse Station, NJ: Merck & Co, Inc; April 2015.
Gardasil 9 [prescribing information]. Whitehouse Station, NJ: Merck & Co, Inc; January 2017.
Gayathri BN, Rao KS. Pancytopenia: a clinico hematological study. J Lab Physicians. 2011;3(1):15-20.
Gazyva [prescribing information]. South San Francisco, CA: Genentech, Inc; February 2016.
Greenlee JE, Wahlen GE. Progressive multifocal leukoencephalopathy (PML). Merck Manual website. http://www.merckmanuals.com/home/brain,-spinal-cord,-and-nerve-disorders/brain-infections/progressive-multifocal-leukoencephalopathy-pml. Accessed January 31, 2017.
Herceptin [prescribing information]. South San Francisco, CA: Genentech, Inc; March 2016.
Herrine SK. Portal hypertension. Merck Manual website. http://www.merckmanuals.com/home/liver-and-gallbladder-disorders/manifestations-of-liver-disease/portal-hypertension. Accessed February 1, 2017.
Howard SC, Jones DP, Pui C-H. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844-1854.
Imlygic [prescribing information]. Thousand Oaks, CA: Amgen Inc; October 2015.
Keytruda [prescribing information]. Whitehouse Station, NJ: Merck & Co, Inc; October 2016.
Lee J. Overview of interstitial lung disease (diffuse parenchymal lung diseases). Merck Manual website. http://www.merckmanuals.com/professional/pulmonary-disorders/interstitial-lung-diseases/overview-of-interstitial-lung-disease. Accessed January 31, 2017.
Mahajan VK, Sharma V, Chauhan PS, et al. Paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome or autoimmune multiorganopathy? Case Rep Dermatol Med. 2012;2012:207126. doi:10.1155/2012/207126.
Mayo Clinic Staff. Diseases and conditions: Stevens-Johnson syndrome. Mayo Clinic website. http://www.mayoclinic.org/diseases-conditions/stevens-johnson-syndrome/basics/definition/con-20029623?p=1. Updated April 22, 2014. Accessed January 31, 2017.
Moake JL. Disseminated intravascular coagulation (DIC). Merck Manual website. http://www.merckmanuals.com/home/blood-disorders/bleeding-due-to-clotting-disorders/disseminated-intravascular-coagulation-dic. Accessed February 2, 2017.
Nivolumab [prescribing information]. Princeton, NJ: Bristol-Myers Squibb Company; November 2016.
Perjeta [prescribing information]. South San Francisco, CA: Genentech, Inc; March 2016.
Rehmus WE. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Merck Manual website. http://www.merckmanuals.com/home/skin-disorders/hypersensitivity-and-inflammatory-skin-disorders/stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten. Accessed January 31, 2017.
Rituxan [prescribing information]. South San Francisco, CA: Genentech, Inc; April 2016.
Sylatron [prescribing information]. Whitehouse Station, NJ: Merck & Co, Inc; September 2015.
Tecentriq [prescribing information]. South San Francisco, CA: Genentech, Inc; October 2016.
Vectibix [prescribing information]. Thousand Oaks, CA: Amgen Inc; March 2015.
Yervoy [prescribing information]. Princeton, NJ: Bristol-Myers Squibb Company; October 2015.
Zevalin [prescribing information]. Irvine, CA: Spectrum Pharmaceuticals, Inc; August 2013.
Thank you for participating in this module. Click below to download the certificate.